We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 48

IOM issues Phase II report recommending energy star-type ratings for a food front-of-package nutrition rating system
  • Kelley Drye & Warren LLP
  • USA
  • October 24 2011

In 2009, Congress requested an Institute of Medicine study examining "front-of-package" ("FOP") nutrition labeling systems and symbols and the effect that FOP labeling could have on consumer food choices


Highlights of FDA’s implementation of the Food Safety Modernization Act in 2013
  • Kelley Drye & Warren LLP
  • USA
  • December 6 2013

On January 4, 2011, President Obama signed into law the Food Safety Modernization Act (FSMA), which has been touted as the most sweeping legislation


8th Circuit Court of Appeals rules false advertising allegations regarding organic claims are not preempted by Organic Foods Production Act of 1990
  • Kelley Drye & Warren LLP
  • USA
  • September 22 2010

The U.S. 8th Circuit Court of Appeals recently ruled that certain false advertising claims based on state consumer protection and anti-deception statutes were not preempted by the Organic Foods Production Act of 1990 (OFPA) a federal Act that establishes national standards for the sale and labeling of organically produced agricultural products, and creates a certification program through which agricultural products may be certified to produce organic products


GAO concludes FDA should strengthen its oversight of GRAS ingredients
  • Kelley Drye & Warren LLP
  • USA
  • March 12 2010

On March 5, 2010, the General Accountability Office (GAO) issued a report evaluating the Food and Drug Administration's (FDA's) policies concerning food ingredients that have been determined to be "Generally Recognized As Safe" (GRAS


FDA partially stays controversial policy of requiring INDs for clinical studies evaluating food, dietary supplements and cosmetics
  • Kelley Drye & Warren LLP
  • USA
  • November 10 2015

On Friday, October 30, 2015, FDA issued a Federal Register Notice announcing a partial stay of the agency's controversial Final IND Guidance entitled


FDA targets antibacterial soaps in new proposed rule
  • Kelley Drye & Warren LLP
  • USA
  • December 17 2013

On Monday, FDA announced a new proposed rule that would amend the 1994 TFM for OTC antiseptic drug products. The change would require companies that


FDA issues an interim final rule and guidance regarding expanded recordkeeping access under the Food Safety and Modernization Act
  • Kelley Drye & Warren LLP
  • USA
  • February 29 2012

On February 23, 2012, the Food and Drug Administration (“FDA”) issued an interim final rule and new guidance regarding provisions of the Food Safety Modernization Act (“FSMA”) that amended recordkeeping requirements of the Food, Drug, and Cosmetic Act (“FDCA”) for entities that manufacture, process, pack, transport, distribute, receive, hold, or import food


FDA announces allowable level for DEHP in bottled water
  • Kelley Drye & Warren LLP
  • USA
  • October 19 2011

On October 19, 2011, the Food and Drug Administration (“FDA”) published a final rule amending its bottled water quality standard regulations by establishing an allowable level of di (2-ethylhexyl)phthalate (“DEHP”


FDA proposes import tolerances for unapproved new animal drugs
  • Kelley Drye & Warren LLP
  • USA
  • February 1 2012

The FDA published a proposed rule to establish procedures by which a person may request that the agency establish, amend or revoke tolerances for unapproved new animal drugs in edible portions of animals imported into the United States as part of its implementation of the Animal Drug Availability Act of 1996


IOM issues Phase I report regarding front-of-package nutrition rating systems and symbols
  • Kelley Drye & Warren LLP
  • USA
  • October 21 2010

In response to the disturbing rates of overweight, obesity, and diet-related chronic disease among Americans, Congress requested an Institute of Medicine (IOM) study that would examine "front-of-package" (FOP) nutrition labeling systems and symbols and the effects that FOP labeling could have on consumer food choices